-
Biological reagents are the foundational tools of biotechnology used to detect, study, modify, or produce biological molecules and cells in support of research, education, and commercialization. For RUN’s purposes, biological reagents specifically include plasmid-based DNA toolkits, microbial strains, mammalian and plant cell lines, reference materials, and assay tools.
-
RUN's initial collections will include plasmid-based toolkits supporting engineering of commonly used laboratory microorganisms, including:
Escherichia coli
Saccharomyces cerevisiae
Komagataella phaffii (formerly Pichia pastoris)
Yarrowia lipolytica
Mammalian Glycobiology (expression of mammalian glycosylation enzymes)
An initial list of DNA toolkits to be distributed during the pilot phase will be available soon.
These plasmid-based DNA toolkits include hundreds of commonly used components such as: promoters, reporter genes, coding sequences, affinity & purification tags, terminators, selection markers, expression vectors, and other useful components.
All materials initially distributed through RUN will be classified as Risk Group 1 (RG1) and suitable for handling under Containment Level 1 (CL1), as defined by the Canadian Biosafety Standard. This corresponds to Biosafety Level 1 (BSL-1) under international terminology.
-
SynBio Canada will maintain the reagent database and take receipt of orders. Only complete kits, not individual plasmids, will be distributed during the pilot project.
Users will pre-order kits they’re interested in. Once enough pre-orders have been placed, reagent production will be initiated.
RUN Distribution Hubs are Canadian organizations with appropriate facilities and capabilities to produce, validate, store, and distribute biological reagents according to RUN standards. Hubs will manage reagent preparation, storage, shipment, payment processing, and required transfer documentation.
Reagents will be distributed under the RUN Material Transfer Agreement (RUN MTA) or OpenMTA, depending on the original source of the reagent.
The RUN MTA is inspired by the OpenMTA, while establishing requirements appropriate for a Canada-focused distribution network. For information regarding the OpenMTA, see here, here, and here.
-
More RUN Distribution Hubs are needed. If you would like to discuss your institute participating as a Hub, complete the Expression of Interest form or contact info@synbiocanada.org.
-
RUN is designed to operate on a cost-recovery basis. Reagent pricing will cover the costs associated with preparation, sequence validation, quality control, storage, administration, and shipping. Pricing is expected to be comparable to established international repositories while reducing barriers associated with international shipping.
-
RUN is currently available only to recipients located in Canada. RUN is intended to support a broad range of users, including academic researchers, non-profit organizations, startups, enthusiasts, entrepreneurs, and established companies engaged in biotechnology research, development, education, and commercialization.
Recipients must confirm that they:
are based in Canada;
have appropriate laboratory facilities;
have personnel trained to safely handle RG1 biological materials;
will follow applicable laws, regulations, and institutional policies; and
agree to the terms of the RUN Material Transfer Agreement.
-
Yes. RUN supports research, development, educational, and commercial activities. Commercial organizations are welcome to receive reagents and use them for commercial purposes, provided they comply with the terms of the signed material transfer agreement and any material-specific conditions.
Supporting responsible commercial use is an important part of RUN's mission. Enabling companies to build upon biological tools developed through public and private research investments helps translate scientific discoveries into products, technologies, and economic benefits for Canada.
-
Receiving a reagent through RUN does not transfer ownership of intellectual property. Recipients of reagents through RUN are responsible for determining their own freedom of use.
-
RUN is currently operating as a pilot program focused on establishing the infrastructure required to distribute reagents across Canada. However, we intend for the future of RUN to include the receipt and redistribution of reagents. If you are interested in contributing reagents please complete the Expression of Interest form.
-
RUN complements, rather than replaces, repositories such as Addgene. While Addgene is a global plasmid repository, RUN is building Canada's biological reagent infrastructure.
-
RUN and Reclone share a commitment to improving access to biological materials and enabling broader use of biotechnology resources.
Reclone focuses on global open access to biotechnology materials, protocols, and knowledge, with particular emphasis on improving equitable access to biotechnology capabilities in the Global South. RUN has a different focus: improving access for researchers and companies operating in Canada while creating a pathway for reagents developed in Canada to become part of a shared national resource.
-
No. RUN is currently intended to serve the Canadian biotechnology community. Reagents are distributed only to eligible recipients located in Canada.
International collaboration remains an important part of biotechnology research, and some materials available through RUN may also be accessible through international repositories under their respective material transfer agreements (i.e. Addgene or Reclone).